Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of KYMR will decline by -5.49% over the next 2 Weeks and hit $64.40 by Tuesday, February 3, 2026. In that time frame, KYMR's share price is expected to range between $56.80 and $71.83.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Feb 3, 2026 | 56.80 | 64.40 | 71.83 |
| Feb 2, 2026 | 59.14 | 66.43 | 73.95 |
| Jan 30, 2026 | 56.76 | 64.28 | 71.66 |
| Jan 29, 2026 | 57.37 | 64.43 | 71.25 |
| Jan 28, 2026 | 58.97 | 66.45 | 73.70 |
| Jan 27, 2026 | 58.71 | 66.28 | 73.85 |
| Jan 26, 2026 | 60.68 | 68.31 | 75.54 |
| Jan 23, 2026 | 59.20 | 66.15 | 73.51 |
| Jan 22, 2026 | 59.44 | 66.31 | 74.07 |
| Jan 21, 2026 | 61.01 | 68.33 | 75.56 |
KYMR shares rose +3.60% in Wednesday, January 21, 2026's trading session, rising from a previous close of $68.14 to move at $70.59. The stock demonstrated notable intraday movement (see KYMR's key stats for a full breakdown), fluctuating between $67.76 and $70.70, a +4.34% trading range. While recent weeks have seen some volatility, KYMR has managed to secure a -3.91% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.02M shares changing hands, 368.53K more than the previous session. This amounted to $72.32M in total market activity.
Will KYMR Continue Its Upward Trend?
According to analyst ratings and projections for KYMR, Kymera Therapeutics, Inc. shares are anticipated to increase by +1.73%, potentially reaching $71.83 per share by February 3, 2026. Short-term technical indicators currently suggest a neutral sentiment for KYMR. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 11 positive trading days within the past 30 sessions. Based on the KYMR stock forecast, now is a good time to buy KYMR stock because its current trading price is +9.61% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on KYMR covering social and institutional perspectives.
KYMR Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into KYMR's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.00% to 46.02%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 52.69%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.38%, maintains a neutral outlook for the long term. Insights into KYMR's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Kymera Therapeutics Short-Term Forecasts
KYMR Forecast For Next 5 Days
Our algorithm anticipates Kymera Therapeutics (KYMR) stock could hit $72.66 by Jan 28, 2026. This represents a +2.93% fall from today's price, following a -6.77% change over the past five days.
KYMR Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Kymera Therapeutics, Inc. (KYMR) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $72.52, which would mean a +2.73% increase from the current price of $70.59. Projections for this period range from a high of $93.87 to a low of $56.98.
KYMR Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Kymera Therapeutics's price over the next three months point to a stability. KYMR stock is expected to peak at $78.16 on Apr 21, 2026 after potentially dipping to $60.67 on Feb 06, 2026. On average, KYMR is likely to trade around $70.59 in the coming 90 days.
Kymera Therapeutics Stock Forecast 2025
Based on our predictive models, Kymera Therapeutics (KYMR) is expected to trade between $60.67 and $94.60 throughout 2026. This would result in an average price of $74.86, potentially offering investors a +6.05% return from current levels.
Kymera Therapeutics, Inc. Monthly Forecast 2026–2027
January 2026
According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in January 2026. The price is predicted to move between $62.55 and $70.93, settling at an average of $66.39. This could translate to a -5.95% loss.
February 2026
Based on current market signals, Kymera Therapeutics, Inc. is projected to trend february 2026. We forecast a trading range from $60.67 to $75.31, with a likely average price of $68.15. Investors could expect a potential return of -3.46%.
March 2026
Our predictive algorithms indicate Kymera Therapeutics, Inc. stock may see a shift in March 2026. The expected range spans $67.30–$77.64, with an average target of $72.29. This represents a positive outlook and a possible gain of +2.41%.
April 2026
Analyzing established trends, Kymera Therapeutics, Inc. looks set to move in April 2026. Projections place the stock between $68.91 and $78.38, averaging around $73.73. This suggests a +4.45% gain from current levels.
May 2026
Market indicators suggest Kymera Therapeutics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $69.97 to $81.77, with a midpoint forecast of $76.22. The stock might deliver a +7.98% gain.
June 2026
Forecasting for June 2026, models estimate that Kymera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $66.27 and $79.68, averaging $72.78. This signals a positive trajectory with potential returns around +3.10%.
July 2026
According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in July 2026. The price is predicted to move between $66.04 and $80.65, settling at an average of $72.99. This could translate to a +3.40% gain.
August 2026
Based on current market signals, Kymera Therapeutics, Inc. is projected to trend august 2026. We forecast a trading range from $72.05 to $81.84, with a likely average price of $76.73. Investors could expect a potential return of +8.70%.
September 2026
Our predictive algorithms indicate Kymera Therapeutics, Inc. stock may see a shift in September 2026. The expected range spans $73.63–$83.05, with an average target of $78.18. This represents a positive outlook and a possible gain of +10.75%.
October 2026
Analyzing established trends, Kymera Therapeutics, Inc. looks set to move in October 2026. Projections place the stock between $73.60 and $86.77, averaging around $80.32. This suggests a +13.78% gain from current levels.
November 2026
Market indicators suggest Kymera Therapeutics, Inc. could experience notable changes during November 2026. Prices could fluctuate within $70.60 to $94.60, with a midpoint forecast of $77.37. The stock might deliver a +9.60% gain.
December 2026
Forecasting for December 2026, models estimate that Kymera Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $70.42 and $84.80, averaging $77.81. This signals a positive trajectory with potential returns around +10.23%.
January 2027
According to our latest forecast models, Kymera Therapeutics, Inc. (KYMR) is positioned to show a strong performance in January 2027. The price is predicted to move between $76.62 and $85.03, settling at an average of $80.83. This could translate to a +14.51% gain.
KYMR's history of dividends and stock splits also plays a role in long-term investor confidence.

